A photo of John Breneman.

Medical Director, Cincinnati Children's Hospital Medical Center/UC Health Proton Therapy Center

Emeritus, Department of Radiation Oncology, The Barrett Cancer Center

513-584-5327

Best Doctors logo

About Me

Clinical Interests

Pediatric cancers

Research Interests

Radiotherapy for pediatric cancers

Learn more about Proton Therapy Center.

Academic Affiliation

Emeritus, Department of Radiation Oncology, The Barrett Cancer Center

Departments

Best Doctors, Neuroblastoma

My Education

BS: Illinois Institute of Technology, Chicago, IL, 1997.

MD: University of Iowa School of Medicine, Iowa City, IA, 1981.

Internship: Butterworth Hospital, Grand Rapids, MI, 1982.

Residency: University of Cincinnati, College of Medicine, Cincinnati, OH, 1985.

My Publications

Breneman JC, et al. The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer. International Journal of Radiation Oncology, Biology, Physics. 2018;101(4):860-874.

Forster N, et al. Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. J Neurooncol. 2018;138(2):335-340.

Hess CB, et al. An Update From the Pediatric Proton Consortium Registry. Front Oncol. 2018;8:165.

Minniti G, et al. Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain. Int J Radiat Oncol Biol Phys. 2018;100(3):535-538.

Ermoian RP, et al. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2017;64(9).

Freese C, et al. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature. Pract Radiat Oncol. 2017;7(2):86-92.

Halasz LM, et al. Treatment of Gliomas: A Changing Landscape. Int J Radiat Oncol Biol Phys. 2017;98(2):255-258.

Walterhouse DO, et al. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2017;123(12):2368-2375.

Brahimaj B, et al. Iodine-125 seed migration within brain parenchyma after brachytherapy for brain metastasis: case report. J Neurosurg. 2016;125(5):1167-1170.

Kirkpatrick JP, et al. Brain Metastases From Melanoma: Therapy at the Crossroads. Int J Radiat Oncol Biol Phys. 2016;96(4):713-716.